Rebecca Weintraub
Dr. Rebecca Weintraub is the Founding Director of the Global Health Delivery Project at Harvard University and co-leads the Global Health Delivery Intensive. She is an Associate Professor in the Department of Global Health and Social Medicine at Harvard Medical School and an Associate Physician at Brigham and Women’s Hospital.
She launched the Better Evidence Program at Ariadne Labs to design, test, and scale strategies to equip the current and future health workforce with the latest evidence to improve health outcomes.
In the midst of the pandemic, Dr. Weintraub expanded her portfolio to support public health decision makers to deliver COVID-19 vaccines. She advises public health departments, employers, HHS, and Ministries of Health. Her work has been published in the New England Journal of Medicine, Nature, Health Affairs, and Harvard Business Review and cited by the New York Times, BBC, Netflix, and NPR.
She was named a Young Global Leader by the World Economic Forum and is a Health Innovator fellow of the Aspen Global Leadership Network. Dr. Weintraub graduated from Yale University, Stanford School of Medicine, and completed her medical training at Brigham and Women’s Hospital.
Dr. Rebecca Weintraub in ABC News story on the funding challenges facing state and local health departments to offer vaccine access to uninsured Americans.
Dr. Rebecca Weintraub in Romper on the Vaccine Equity Planner and the continued challenge of finding vaccines for kids under 5.
Dr. Rebecca Weintraub in Devex on how digital applications can help close gaps and empower community health workers to expand from disease interventions to comprehensive care focused on health and well-being.
The Harvard T.H. Chan School of Public Health highlights the Global Health Delivery Intensive program as it enrolls its 15th annual session.
Dr. Rebecca Weintraub and colleagues pen a perspective in ABC News on the challenges ahead to vaccinate the youngest population.
By Merrick Schaefer, Julie Rosenberg, Iman Ahmad, Ariel Frankel, and Rebecca Weintraub The Ministry of Health just established the COVID-19 Recovery Task Force to get the entire population of your country vaccinated as efficiently and equitably as possible. You are being brought on to develop a strategy and manage the roll out and scale up… Continue reading Digital Game from USAID and TechChange Teaches Health Managers to Navigate Challenges of a Global Pandemic
By Rebecca Weintraub, MD Like many families, we watched summer plans for our two children dissolve as the COVID-19 pandemic raged unchecked and travel restrictions mounted, forcing many camps to go virtual or shut down. As we scrambled to find alternatives, we learned of two camps opening in-person in Maine, a state within driving distance… Continue reading Serving as a First Time Camp Doctor in the Midst of a Pandemic: Lessons in Adaptive Leadership
By Laura Subramanian, Anthony McDonnell, Robert Van Exan, Julie Rosenberg, Prashant Yadav, and Rebecca Weintraub As the world awaits the results of COVID-19 vaccine clinical trials, we need to invest now in systems to ensure equitable global vaccine delivery. Sixteen vaccine experts from the vaccine industry, academic and regulatory agencies interviewed by the Center for… Continue reading Vaccine experts speak out on COVID-19 vaccines and how to prepare
Drs. Rebecca Weintraub and Asaf Bitton are signatories on the latest report of the CSIS Working Group on Routine Immunizations and Global Health Security.
When COVID-19 vaccines become available in the US, states will need to allocate them to their highest priority populations. The Vaccine Allocation Planner for COVID-19 helps state and county decision prepare for different scenarios.
Our Better Evidence team in BMJ Global Health on finding that the data on the current medical school landscape in Africa was outdated, incomplete and needing updating. Their research identified 444 medical schools in Africa, a 160+% increase from the previous estimate of 169 schools in 2010.
Dr. Rebecca Weintraub in Vaccine Insights explaining the COVID-19 Vaccine Allocation Planner and the Vaccine Equity Planner.
Published in the American Journal of Public Health, Ariadne Labs, together with Boston Children’s Hospital and Google, share lessons learned from the Vaccine Equity Planner and how the tool can identify “vaccine deserts” and support decision makers.
Our Better Evidence team published in BMJ Open on the barriers and facilitators of UpToDate use in resource-limited settings.
Our Better Evidence team published in JMIR Formative Research on the analysis of clickstream data from UpToDate users in resource-limited settings.
